Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
  • A61K9/2806—Coating materials
  • A61K9/2833—Organic macromolecular compounds
  • A61K9/2873—Proteins, e.g. gelatin
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01C—PLANTING; SOWING; FERTILISING
  • A01C1/00—Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
  • A01C1/06—Coating or dressing seed
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
  • A23B9/00—Preservation of edible seeds, e.g. cereals
  • A23B9/14—Coating with a protective layer; Compositions or apparatus therefor
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
  • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
  • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
  • A23G3/343—Products for covering, coating, finishing, decorating
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
  • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
  • A23P20/10—Coating with edible coatings, e.g. with oils or fats
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
  • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
  • A23P20/10—Coating with edible coatings, e.g. with oils or fats
  • A23P20/105—Coating with compositions containing vegetable or microbial fermentation gums, e.g. cellulose or derivatives; Coating with edible polymers, e.g. polyvinyalcohol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
  • A61K9/2806—Coating materials
  • A61K9/2833—Organic macromolecular compounds
  • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
  • A61K9/2806—Coating materials
  • A61K9/2833—Organic macromolecular compounds
  • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
  • A61K9/2806—Coating materials
  • A61K9/2833—Organic macromolecular compounds
  • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
  • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
  • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
  • A61K9/2806—Coating materials
  • A61K9/282—Organic compounds, e.g. fats
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/20—Pills, tablets, discs, rods
  • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
  • A61K9/2806—Coating materials
  • A61K9/2833—Organic macromolecular compounds
  • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Definitions

• This invention relates to the field of aqueous film coating of pharmaceutical, food, confectionery, and agricultural products, and is specifically concerned with providing film coatings having an elegant, extremely glossy, and smooth appearance.
• Coating of pharmaceutical dosage forms is well known in the industry. Film coating systems that impart a finished tablet gloss also are known. Cellulosic polymers, maltodextrin, and other polymers have all been used in coatings for substrates such as pharmaceutical tablets, and to some degree impart a desired "coated tablet” appearance or gloss to the pharmaceutical tablets.
• coatings made from coating compositions manufactured by Colorcon, of West Point, PA, and disclosed in Colorcon U.S. Patent Nos. 4,543,370, 4,683,256, 4,643,894, 4,725,441, 4,828,841, and 5,470,581, Colorcon U.S.
• Sadek et al U.S. Patent No. 5,146,730 discloses a method of coating a tablet by enrobing the tablet in a gelatin coating by application of respective layeis ot elastic gelatin film to opposite sides of the tablet. Sadek et al . U.S. Patent No. 5,146,730 discloses that it is essential to use gelatin with bloom values in the range of 120 to 250 to produce the desired film elasticity and adhesion characteristics.
• Becker U.S. Patent No. 5,114,720 discloses a method for coating previously coated tablets with a solution consisting essentially of only a low bloom gelatin (from pork, calfskin or bone) and water for the purpose of imparting a low coefficient of friction, and thus an increased slipperiness and swallowability to the tablet. There is no mention of improved gloss or smoothness .
• U.S. Patent No. 4,931,286 discloses a high gloss pharmaceutical tablet with an outermost coating of sodium carboxymethylcellulose and a polyethylene glycol plasticizer wheima the outt.rruut;i coating is applied from a water solution by spray- coat g.
• a coated tablet has a hazy appearance .
• Another object of the invention is to provide a f lm coating that possesses an elegant, extremely glossy, and smooth appearance . Another object of the invention is to provide a film coating that does not have a frost-like haze.
• Another object of the invention is to provide a film coating from a film coating suspension that may be spray-coated onto tablets and the like at high weight gains substantially higher than l.O-o to produce film coatings having an exceptional shine and smoothness comparable to coatings produced by gel -dipping or enrobing and/or sugar-coating.
• Another object of the invention is to provide a film coating from a film coating suspension that may be spray-coated onto tablets and the like using coating conditions typical to traditional spray-coating equipment .
• inventive dry film coating composition disclosed herein is mixed into water to create an aqueous coating suspension which is spray-coated onto pharmaceutical tablets, producing a smooth and glossy appearance similar to currently marketed gel -dipped, enrobed or sugar-coated medicinal forms, which heretofore has not been obtained, or believed to be obtainable, by spray-coating.
• An added benefit to the present invention is that the inventive coating may be formed by spray-coating at weight gains substantially higher than 1% (by dry weight basis) to produce a similar coating thickness as currently commercial gel -dipped or enrobed products, without creating a frost -like or ha appearance in the coating.
• the coating of the present invention may be applied to tablets and the like by using traditional spray-coating equipment and room temperature mixing conditions, it represents a substantial time-savings in processing over traditional gel -dipping or sugar- coating processes, which are well-known to be lengthy processes. Further, because the coating of the invention may be applied to tablets and the like by using room temperature mixing conditions and spray- coating conditions typical to traditional spray-coating equipment, application of the film coating is easier than application of a film coating using elevated temperature mixing conditions and nun- traditional spray-coating conditions such as those disclosed in Shen U.S. Patent No. 5,683,717.
• inventive dry film coating composition may be mixed into water to create an aqueous coating suspension that may be used for dipping or enrobing substrates, such as pharmaceutical substrates, food, con ectionery pieces, agricultural seeds, and the like.
• our dry film coating composition for use in forming a coating suspension for film coating pharmaceuticals, food, confectionery forms, agricultural seeds, and the like, comprises gelatin and/or hydroxyethyl cellulose (HEC) , and one or more of the following components: a secondary film former(s), a plasticizer (s) , a surfactant (s) , a glidant (s) , a suspension aid(s), a colorant (s) , and/or a flavorant (s) .
• HEC hydroxyethyl cellulose
• a method of coating substrates such as pharmaceutical tablets, food, confectionery forms, agricultural seed, and the like, comprises mixing gelatin and/or HEC into water to form our inventive aqueous coating suspension, applying the inventive coating suspension onto said substrates to form a film coating on said substrates, and drying the film coating on said substrates.
• one or more of the following components may be mixed into water with the gelatin nd/or HEC to form the inventive coating suspension: a secondary film former(s), a plasticizer (s) , a surfactant (s) , a glidant (s), a suspension aid(s), a colorant (s), and/or a flavorant (s) .
• Our invention also includes the film coating formed on said substrates, the coated substrates, and the methods of making the dry film coating composition and of making our coating suspension.
• the film former of the coating is hydroxyethyl cellulose (HEC), or low bloom strength, non-gellmg gelatin (preferably, fish gelatin) , or combinations thereof .
• the secondary film former may be sodium alginate, sodium carboxymethylcellulose (NaCMC) , pectin, gelatin, propylene glycol alginate, methylcellulose , polydextrose, polyvinylpyrrolidone, or combinations thereof .
• the plasticizer may be glycerin, maltitol solution, propylene glycol, polyethylene glycol, triethyl citrate, glyceryl triacetate, or any other material of similar plasticizing ability, or combinations thereof.
• the surfactant may be soya lecithin, sodium lauryl sulfate, polysorbate 80, or polyoxyethylene polyoxypropylene block copolymers, or combinations thereof .
• the glidant may be talc, colloidal silicon dioxide, or stearic acid, or combinations thereof.
• the suspension aid may be xanthan gum, propylene glycol alginate, or pectin, or combinations thereof.
• the colorants may be FDS-C and D&C lakes, titanium dioxide, iron oxides, natural pigments, or dyes approved for ingestion by the U.S. Federal Drug
• the flavoran (s) which is used primarily for taste- and/or odor-masking, may be vanillin, sodium citrate, citric acid, mint, orange, lemon oil, or any other pharmaceutically approved flavorant or tastemasking agent, and combinations thereof. Vanillin and citric acid are preferred.
• the most preferred ranges for the fish gelatin and/or HEC is 50-65% by weight of the dry film coating composition, the most preferred ranges for the secondary film former are 20-40% by weight of the dry film coating composition, and the most preferred ranges for the plasticizer are 4-10% by weight of the dry film coating composition.
• compositions which may be mixed into ambient temperature water to form an aqueous coating suspension effective to coat pharmaceutical tablets, food and confectionery pieces, and agricultural seeds. Seeds are advantageously coated to meet various needs, such as color coating for identification purposes, adhesion of various additives, (e.g., pest control agents and inocula) , prevention of handling damage, and facilitating the use of mechanical planting equipment.
• various additives e.g., pest control agents and inocula
• coated forms of these examples include, but are not limited to, medicinal tablets such s aspirin tablets, acetaminophen caplets and ibuprofen tablets, vitamin tablets, and placebos, agricultural seeds and food substrates, such as chewing gum balls, candy pieces, and breakfast cereals.
• a formulation for the present inventive dry coating composition is the following:
• Spray-dried Hydrolyzed Fish Gelatin from Croda Colloids is a cold-water soluble, non-gelling gelatin derived from fish sources, and is the film former.
• NaCMC Sodium Carboxy methyl Cellulose from Montello, and is the secondary film former.
• Soya Lecithin (surfactant) is Alcolec F-100 from American Lecithin.
• PGA suspension aid
• Citric Acid Monohydrate (ADM) and Vanillin (Rhodia) are flavorants.
• the coating suspension is prepared by weighing all ingredients into a suitable-sized food processor/blender and blending for 5 minutes- until a homogeneous mixture is produced.
• the ingredients of this formulation are all dry powders, but for purposes of clarification and in examples to follow, if any liquid ingredients are present in the formula, they are added after the initial blending of dry ingredients, and blending is then continued for an additional 5 minutes after all liquid has been introduced.
• blenders such as a
• Blending of the aforementioned formulation also may be achieved by processing ingredients into a granular form to produce a non-dusting granular coating composition by the following methods: wet massing, fluid bed granulation, spray granulation and dry compaction, roller compaction or slugging.
• the speed and depth of the mixing blade is adjusted to avoid air being drawn into the suspension so as to avoid foaming.
• the suspension is stirred for 45 minutes and is then ready for spraying onto substrates like pharmaceutical tablets.
• the viscosity of this suspension ranges from 80cP - 90cP, as measured by Brookfield Rotational Viscometer Model DV-II+, spindle 1, 20 rpm, setting S-61.
• gloss is typically and easily assessed by visual comparison of one finished product to. another, the degree of coated tablet gloss is measured by Tricor Systems Gloss Analysis System Model 801A, used widely in industry to measure luster and sheen on automotive surfaces, on vinyl and in paints. This system measures the specular component of light reflecting off the samples, allowing for the measurement of gloss regardless of the shape, texture or color of the samples. All gloss measurements are directly traceable to a gloss reference standard, which is used to calibrate the instrument daily.
• the gloss reading attained for the coating of this specific example was 207 gloss units (g.u.) .
• Typical gloss readings attained for standard commercially available gel -dipped or enrobed tablets range from 200 to 240 gloss units (g.u.).
• Gloss readings for standard commercially available sugar-coated medicaments range from 177 to 209 g.u.
• a coating mixture having the following formula is made using the procedure of Example 1 :
• HEC Hydroxy Ethyl Cellulose
• PVP Polyvinylpyrrolidone
• HEC is the film former of the composition and is
• PVP is the secondary film former and is Kollidon 30 supplied by BASF.
• Maltisweet 3145 is maltitol solution manufactured by SPI Polyols and is the plasticizer.
• Polyoxomer 188 is Pluronic F68NF (surfactant) , and is supplied by BASF.
• the coating suspension using the coating mixture of this example is made using the procedure of Example 1, and 300 grams of ibuprofen tablets (200mg) , previously coated at a 4.0% weight gam with a coating made from an Opadry ® II coating composition, formula 49B13354 (orange) , manufactured by Colorcon and made in accordance with the disclosure in Colorcon U.S. Patent No.
• a coating suspension is prepared having the same formula as in Example 2, and 300 grams of 10mm deep convex aspirin cores, previously coated at a 4.0% weight gain with a coating made from an Opadry ® AMB coating composition (light orange) manufactured by Colorcon, and made in accordance with the disclosure Colorcon U.S Patent Application No. 08/466,939, are spray-coated with the coating suspension of this example using the procedure of Example 1.
• a 5.0% weight gain is applied to the cores, and the finished product is smooth, non-tacky, and yielded a gloss measurement of 215 g.u.
• Example 4 A coating suspension is prepared having the same formula as in Example 2, except that Polyoxomer 237 (Pluronic F87) is substituted for Polyoxomer 188 (Pluronic F68NF) in the formulation at the same percentages, and 300 grams of 11mm extra deep convex placebos, previously coated using the Opadry ® II coating composition mentioned in Example 1, are spray- coated with the coating suspension of this example using the procedure of Example 1. A 3.0% weight gain is applied, and the resultant tablets are very smooth, non-tacky, and very shiny with a gloss measurement of
• a dry coating composition having the following formula is made using the procedure of Example 1: Component Percent grams
• HEC Hydroxy Ethyl Cellulose
• a coating suspension is prepared using the coating composition of this example and the procedure of
• Example 1 and 300 grams of placebo tablets, which have been previously coated as in Example 1, are spray- coated with the inventive coating suspension of this example using the procedure of Example 1.
• Example 6 A dry coating composition having the following formula is made using the procedure of Example 1:
• Citric Acid Monohydrate 2.0 4.0 Vanillin 2.0 4.0 Xanthan Gum 1.0 2.0
• Xanthan Gum is Xantural 180 supplied by Monsanto and is functioning as a further suspension aid for the formulation, and Polysorbate 80, of vegetable source, supplied by Cesalpina, is functioning as a further surfactant in the formula.
• Example 2 150 grams of the dry coating composition is dispersed in 2850 grams of ambient water using the procedure of Example 1 and stirred for 45 minutes to create an aqueous coating suspension having a 5.0% solids content.
• the suspension viscosity is 124 cP.
• the atomizing air is 25 psi
• pattern air is 30 psi
• inlet air temperature is 74°C
• outlet air is 50°C
• the tablet bed temperature is at 40°C
• the pan speed is 16 rpm
• the coating liquid feed rate is 20 g/min
• the total coating time is 2 hrs and 34 minutes.
• a theoretical 5.0 % dry coating weight gain is applied to the tablet charge, producing very smooth, non-tacky, very shiny coated tablets registering 211 g.u.
• a dry coating composition having the following formula is made using the procedure of Example 1 : Component Percent grams
• Example 2 50 grams of the dry coating composition is dispersed in 950 grams of ambient water using the procedure of Example 1 to create an aqueous coating suspension having a 5.0% solids content.
• Y-41-15146 (red) , manufactured by Colorcon and disclosed in U.S. Patent Application Serial No. 08/778,944, is loaded into a 12" O ' Hara Labcoat I coating pan with 4 mixing baffles and 6 anti-slide bars.
• the aqueous coating suspension is sprayed onto the tablet bed using 1 Spraying System Gun, 1/8 VAU SS and a Masterflex digital console peristaltic pump with 1 7518-02 pumphead.
• the atomizing air is 20 psi
• pattern air is 25 psi
• inlet air temperature is 74°C
• outlet air is 50°C,.
• the tablet bed temperature is at 35°C
• the pan speed is 18 - 20 rpm
• the coating liquid feed rate is 12 g/min
• the total coating time is 1 hr and 20 minutes.
• a theoretical 5.0 % dry coating weight ga is applied to the tablets, producing very smooth, non-tacky, very shiny coated vitamin tablets with a slick feel registering 235 g.u.
• the coating suspension is made as m Example 7, and uncoated multivitamm tablets aie spray-coated using the coating procedure of Example 7. Gloss units attained were 220 g.u.
• the individual ingredients of each formulation may be mixed directly into water to form the coating suspension.
• PEG 400 is Polyethylene Glycol 400 from Clariant and functions as a plasticizer.
• Example 10 Component Percent grams
• Glycerin is manufactured by Dow Chemical and functions as a plasticizer.
• Propylene Glycol is supplied by Dow Chemical and functions as a plasticizer.
• Fish Gelatin is supplied by Norland Products Inc. and is the film former.
• Triethyl citrate is supplied by Morflex and functions as a plasticizer.
• Lycasin is maltitol solution supplied by Roquette and functions as a plasticizer in combination with PEG 3000 which is Polyethylene Glycol 3000 from Clariant.
• Citric Acid Monohydrate 2 0 2.0
• Natural Special Compound is a taste/odor-masking compound supplied by Firmenich.
• Example 15 Component Percent grams
• Sodium Alginate is Keltone LVCR from Monsanto and functions as a secondary film former.
• Lycasin 5.0 Natural Lemon 2.0 2.0 Genu Pectin 2.0 2.0 Pluronic F87 2.0 2.0
• Genu Pectin is supplied by Hercules and is a suspending agent in the formula.
• Natural Lemon is supplied by Firmenich, and is a flavorant.
• Pectin is the secondary film former of the formula.
• Triacetin is glyceryl triacetate supplied by Eastman, and functions as the plasticizer
• Colloidal Silicon Dioxide is Cabosil supplied by Cabot and is the glidant.
• Methylcellulose is Metalose ⁇ M15 from Shinetsu and is the secondary film former of the formula.
• Example 22 Component Percent grams
• PVP and Fish Gelatin in combination are the secondary film former.
• a dry coating composition having the following formula is made using the procedure of Example 1: Component Percent grams HEC 54.0 54.0 PVP 25.0 25.0
• Polydextrose is Litesse supplied by Cultor and is functioning as a secondary film former in combination with polyvinylpyrrolidone (PVP) .
• PVP polyvinylpyrrolidone
• Fifty grams of the dry coating compostion is dispersed in 950 grams of ambient water using the procedure of Example 1 to create an aqueous coating suspension having a 5.0% solids content.
• a 1.0 kilogram charge of 500 ' mg Acetaminophen caplets, which have been previously coated with a theoretical 3.0% weight gain of a pigmented film coating made from an Opadry ® II coating composition, as explained in Example 1, are spray- coated with the inventive aqueous coating suspension of this example using the coating procedure of Example 7. Gloss units attained were 225 gu.
• a dry coating composition having the following formula is made using the procedure of Example 1 :
• the aqueous coating suspension is sprayed onto the tablet bed using 2 Schlick Guns, Model 930-33/7-1, with 1.2 mm spray nozzles and 3.0 mm air caps; and a Masterflex digital console peristaltic pump equipped with two 7518-02 pumpheads .
• the atomizing air is 50 psi
• pattern air is
• inlet air temperature is 75°C
• outlet air is 48°C
• the tablet bed temperature is at 43° - 45°C
• the pan speed is 10 - 12 rpm
• the coating liquid feed rate is 125 g/min.
• a theoretical 5.0% dry coating weight gain is applied to the tablet charge, producing very smooth, non-tacky, very shiny coated tablets with a gloss reading of 205 g.u.
• a colorant may be incorporated into the formulation of the invention, if desired, to eliminate the step of applying a colored subcoat, as illustrated in this example.
• a dry coating composition having the following formulation is made using the procedure of Example 1:
• Stearic Acid is from Oleotec Ltd., and is the glidant.
• Ti02 is Titanium Dioxide from Kronos , and
• FDScC Blue No. 2 Lake is manufactured by Colorcon, West Point, PA.
• a coating suspension is made by dispersing 10.5 grams of the dry coating composition of this example into 94.5 grams of purified water to create a suspension having a 10.0% solids context. Coating is performed on a 300 gram mixed charge of aspirins and placebos in an Aeromatic Strea-1 coater as in Example 1, and a theoretical 3.5% weight gain is applied to the tablets. Tablets are smooth, evenly pigmented, and of suitable shine with a gloss measurement of 148 gloss units .
• Example 34 is repeated, except the following formulation is used:
• D&C Yellow No. 10 dye is manufactured by Hilton Davis. Talc is Altaic 400 from Whittaker, Clark and
• Example 36 This example illustrates the use of a liquid color premix as the colorant for coloring the inventive film coating.
• the dry coating composition of Example 28 is prepared and then mixed into water using the procedure of Example 7 to form a coating suspension having a 5% solids content.
• 950 grams of this suspension is then placed into an empty vessel, and 12.5 grams of an Opatint ® (DD11000 (green)) liquid color dispersion (containing 20% dry solids) (a liquid color premix) , manufactured by Colorcon, is added ana mixed into the suspension producing a colored suspension having a total dry solids weight of 50.0 grams in the colored suspension.
• the percentage of inventive coating suspension to color is at a ratio of 95:5.
• a 1.0 kilogram charge of uncoated 11 mm deep convex placebos is loaded into a 12" O'Hara coating pan and the colored coating suspension prepared as stated above is spray-coated using the procedure of Example 7.
• a theoretical 5.0% dry coating weight gain is applied to the tablets producing very elegant, glossy tablets with a gloss measurement of 196 g.u.
• Example 7 The dry coating composition of Example 7 is prepared and then mixed into water using the procedure of Example 6 to form a coating suspension. This coating suspension then is applied by spray-coating in a 15" O'Hara coating pan using the procedure of Example
• Example 7 The dry coating composition of Example 7 is prepared and then mixed into water using the procedure of Example 6 to from a coating suspension. This coating suspension then is applied by spray-coating in a 15" O'Hara coating pan using the procedure of Example 6 onto a 3.0 kilogram charge of uncoated 500 mg Acetaminophen caplets. A 5% dry coating weight gain is applied to the caplets, and the coated caplets are very elegant with a gloss measurement of 191 g.u. Then using a Hartnett Delta printer coated caplets of this example are printed with a white Opacode ® ink, formulation S-l-7090, an alcohol-based printing ink manufactured by Colorcon, West Point PA. The ink transferred to the coated tablets completely, with excellent adhesion.
• Example 6 The dry coating composition of Example 6 is prepared and then mixed into water following the procedure of Example 6 to from an aqueous coating suspension.
• a 3.0 kilogram charge of 3/8" diameter placebos which have been previously coated with a coating made from a red Opadry ® II coating composition, manufactured by Colorcon, is spray-coated with the coating suspension of this example in a 15" O'Hara Labcoat II pan with 4 mixing baffles and 6 anti-slide bars.
• Two Schlick Spray guns Model #931/7-1 S22 are used to deliver the coating suspension through a Masterflex digital console peristaltic pump with 2 7518-02 pumpheads .
• the atomizing air is 30 psi
• pattern air is 35 psi
• inlet air temperature is 65°C
• outlet air is 44°C
• the tablet bed temperature is 41°C
• pan speed is 18 rpm
• the coating liquid feed rate is 30 g/min
• the total coating time is 1 hour and 50 minutes.
• a 5%. dry coating weight gain is applied to the tablets, and the coated tablets are non-tacky, extremely smooth, and glossy with a gloss reading of 218 g.u.
• inventive dry coating compositions may be used to create aqueous coating suspensions that are applied to substrates, such as pharmaceutical substrates, by dipping or enrobing, as illustrated in this example.
• the a dry coating composition of Example 6 is prepared and then mixed into water following the procedure of Example 1 to form 5.0% solids aqueous coating suspension.
• the suspension is allowed to deaerate to remove any bubbles.
• Aspirin tablets which have been previously coated with a 3.0% weight gain of a pigmented film coating made from an Opadry ® II coating composition, formula Y-22-15118 (red) , manufactured by Colorcon, West Point PA, are individually dipped into the coating suspension by using a pair of forceps. Excess coating is removed by shaking each tablet after dipping.
• Coated tablets are then slowly rotated by hand under a forced air dryer for 1 to 2 minutes until the coating sets slightly, and then the tablets are placed in a plastic weigh boat under the air dryer to dry for an additional 15 minutes. After drying, tablets are visually inspected for film-coat quality and gloss measurement.
• the coated tablets of this example are exceptionally glossy and smooth, reflective, bright and elegant looking.
• the dry film coating composition of Example 28 is made using the procedure of Example 1, and the coating composition is mixed into water using the procedure of Example 1 to form an aqueous coating suspension having a 15% solids content.
• Aspirin tablets, having a previously applied coating (a subcoat) are dipped into the suspension following the procedure of Example 40 to form an inventive coating on the tablet over the subcoat.
• the resultant tablets are elegant looking, and exceptionally glossy and smooth.
• the gloss measurement attained is 243 g.u.
• Example 43 Hydroxy ethyl cellulose is dispersed in ambient water to produce a clear solution having a 10% solids content. The solution is allowed to deaerate to remove any bubbles. Aspirin tablets, having a previously applied subcoat, are dipped into the suspension following the procedure of Example 40 to form an inventive coating on the tablets over the subcoat. The resultant coated tablets are elegant looking, and exceptionally glossy and smooth. The gloss measurement attained is 202 g.u.
• film coating suspensions may be spray-coated onto tablets and the like at weight gains substantially higher than 1.0% to produce film coatings having an exceptional shine and smoothness not achieved with the inventions of the aforementioned patents. Moreover, our coatings do not have a frost-like or hazy appearance.
• a coating is produced that has a finished product gloss and smoothness comparable to the current commercially marketed medicaments that are gel -dipped or enrobed and/or sugar-coated.
• Non-pigmented inventive coatings may be applied to tablets and the like as an overcoat to a substrate previously coated with a pigmented aqueous coating. Also, clear coatings made in accordance with the invention may be used as a stand alone clear coating for a non-pigmented, non-coated substrate. Non-clear coatings (coating having pigments and/or colorants) made in accordance with the invention, as well as the inventive clear coatings, have a smooth and glossy appearance .
• Another advantage of the present invention is the exceptional slip afforded the tablets after coating.
• the tablets slide off one another, contributing to ease of packaging and ease of ⁇ wallowing for the consumer.
• the slick surface of the finished tablet product is not deleterious to printing.
• inventive coating may be applied to tablets and the like by using traditional spray-coating equipment, traditional spray-coating equipment conditions, and room temperature mixing conditions, which represents substantial time-savings and substantial labor-savings in processing over traditional gel -dipping processes, traditional sugar- coating processes, and processes like that of Shen U.S.
• Patent No. 5,683,717 discloses a patent No.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Chemical & Material Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• General Health & Medical Sciences (AREA)
• Polymers & Plastics (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Epidemiology (AREA)
• Animal Behavior & Ethology (AREA)
• Food Science & Technology (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Biotechnology (AREA)
• Soil Sciences (AREA)
• Environmental Sciences (AREA)
• Wood Science & Technology (AREA)
• Zoology (AREA)
• Medicinal Preparation (AREA)

Priority Applications (3)

Applications Claiming Priority (6)

Publications (2)

Family

ID=27400867

Family Applications (1)

Country Status (4)

Cited By (8)

Citations (8)

Family Cites Families (3)

• 2000
  • 2000-02-18 WO PCT/US2000/004980 patent/WO2000048574A1/en not_active Application Discontinuation
  • 2000-02-18 AU AU37088/00A patent/AU3708800A/en not_active Abandoned
  • 2000-02-18 CA CA002362356A patent/CA2362356A1/en not_active Abandoned
  • 2000-02-18 EP EP00915891A patent/EP1169022A4/de not_active Withdrawn

Patent Citations (9)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events